IFNG and neoplasm: Major impairments in the generation of anti-tumor immunity, include the paucity of tumor neoantigens, impaired antigen presentation, lack of T cell priming and activation, poor tumor infiltration by activated T cells, poor tumor cell recognition/impaired IFN-γ signaling, and alterations in the composition and properties of immune cells within the peripheral TIME (Figure 2).